Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007

References

• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology. 1999; 52: 504–9
   PubMed Web of Science ®Google Scholar
• The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992;55:536–41.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology. 1986; 5: 61–70
   PubMedGoogle Scholar
• Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56:239–44.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005; 76: 1094–8
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007; 68: 141–5
   PubMed Web of Science ®Google Scholar
• Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, et al. Incidence of amyotrophic lateral sclerosis and of the Parkinsonism-dementia complex of Guam, 1950–1989. Neuroepidemiology. 2004; 23: 192–200
   PubMed Web of Science ®Google Scholar
• Yoshida S, Uebayashi Y, Kihira T, Kohmoto J, Wakayama I, Taguchi S, et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989–1993: active or disappearing focus?. J Neurol Sci. 1998; 155: 146–55
   PubMed Web of Science ®Google Scholar
• Vazquez MC, Ketzoian C, Legnani C, Rega I, Sanchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology. 2008; 30: 105–11
   PubMed Web of Science ®Google Scholar
• Lai CH, Tseng HF. Epidemiology and medical expenses of motor neuron diseases in Taiwan. Neuroepidemiology. 2008; 31: 159–66
   PubMed Web of Science ®Google Scholar
• Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996; 15: 239–45
   PubMed Web of Science ®Google Scholar
• Preux PM, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, et al. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000; 53: 1025–9
   PubMed Web of Science ®Google Scholar
• Insee. Recensement de la population, mars 1999. 1999, [cited 2008 Sept 30]; Available from:, http://www.recensement.insee.fr/RP99/rp99/page_accueil.paccueil.
   Google Scholar
• ORS du Limousin. Le contexte géographique et économique. 2003, [cited 2008 Sept 30]; Available from:, http://www.ors-limousin.org/dmdocuments/contex_geo_eco.pdf.
   Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293–9
   PubMed Web of Science ®Google Scholar
• Couratier P, Druet-Cabanac M, Truong CT, Bernet-Bernady P, Dumas M, Vallat JM, et al. Interest of a computerized ALS database in the diagnosis and follow-up of patients with ALS. Rev Neurol (Paris) 2000; 156: 357–63
   PubMed Web of Science ®Google Scholar
• Desport JC, Marin B, Funalot B, Preux PM, Couratier P. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008; 9: 273–8
   PubMed Web of Science ®Google Scholar
• Preux PM, Couratier P, Boutros-Toni F, Salle JY, Tabaraud F, Bernet-Bernady P, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology. 1996; 15: 153–60
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999; 53: 1059–63
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 91–6
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001; 74: 328–34
   PubMed Web of Science ®Google Scholar
• Couratier P, Vincent F, Torny F, Lacoste M, Melloni B, Lemaire F, et al. Spirometer-dependence of vital capacity in ALS: validation of a portable device in 52 patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 239–45
   PubMed Web of Science ®Google Scholar
• Gil J, Preux PM, Alioum A, Ketzoian C, Desport JC, Druet-Cabanac M, et al. Disease progression and survival in ALS: first multi-state model approach. Amyotroph Lateral Scler. 2007; 8: 224–9
   PubMed Web of Science ®Google Scholar
• Insee. Estimation annuelle de population au 1er janvier par région, département, sexe et âge, 1990–2006. 2006, [cited 2008 Sept 30]. Available from:, http://www.insee.fr/fr/themes/detail.asp?ref_id=estim-pop&reg_id=99.
   Google Scholar
• US Census Bureau. United States 2000 Census. 2000, [cited 2008 Sept 30]; Available from:, http://www.census.gov/main/www/cen2000.html.
   Google Scholar
• Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta. 2006; 1762: 1150–7
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol. 2007; 254: 866–9
   PubMed Web of Science ®Google Scholar
• Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2007; 29: 44–8
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008; 79: 6–11
   PubMed Web of Science ®Google Scholar
• Alcaz S, Jarebinski M, Pekmezovic T, Stevic-Marinkovic Z, Pavlovic S, Apostolski S. Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurol Scand. 1996; 94: 264–8
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003; 60: 683–9
   PubMed Web of Science ®Google Scholar
• Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925–1998. Neurology. 2002; 59: 280–2
   PubMed Web of Science ®Google Scholar
• O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008; 79: 30–2
   PubMed Web of Science ®Google Scholar
• Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68: 1002–7
   PubMed Web of Science ®Google Scholar